Search Results - Nayak-Kapoor, Asha
- Showing 1 - 9 results of 9
-
1
Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes by Lu, Chunwan, Klement, John D., Ibrahim, Mohammed L., Xiao, Wei, Redd, Priscilla S., Nayak-Kapoor, Asha, Zhou, Gang, Liu, Kebin
Published 2019Text -
2
-
3
Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: a Phase I Study by Zamarin, Dmitriy, Hamid, Omid, Nayak-Kapoor, Asha, Sahebjam, Solmaz, Sznol, Mario, Collaku, Agron, Fox, Floyd E., Marshall, Margaret A., Hong, David S.
Published 2020Text -
4
CD133(+)CD24(lo) defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype by Paschall, Amy V., Yang, Dafeng, Lu, Chunwan, Redd, Priscilla S., Choi, Jeong-Hyeon, Heaton, Christopher M., Lee, Jeffrey R., Nayak-Kapoor, Asha, Liu, Kebin
Published 2016Text -
5
Deregulation of Apoptotic Factors Bcl-xL and Bax Confers Apoptotic Resistance to Myeloid-derived Suppressor Cells and Contributes to Their Persistence in Cancer by Hu, Xiaolin, Bardhan, Kankana, Paschall, Amy V., Yang, Dafeng, Waller, Jennifer L., Park, Mary Anne, Nayak-Kapoor, Asha, Samuel, Thomas A., Abrams, Scott I., Liu, Kebin
Published 2013Text -
6
H3K9 Trimethylation Silences Fas Expression to Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance by Paschall, Amy V., Yang, Dafeng, Lu, Chunwan, Choi, Jeong-Hyeon, Li, Xia, Liu, Feiyan, Figueroa, Mario, Oberlies, Nicholas H., Pearce, Cedric, Bollag, Wendy B., Nayak-Kapoor, Asha, Liu, Kebin
Published 2015Text -
7
Restoring FAS Expression via Lipid-Encapsulated FAS DNA Nanoparticle Delivery Is Sufficient to Suppress Colon Tumor Growth In Vivo by Merting, Alyssa D., Poschel, Dakota B., Lu, Chunwan, Klement, John D., Yang, Dafeng, Li, Honglin, Shi, Huidong, Chapdelaine, Eric, Montgomery, Mitzi, Redman, Michael T., Savage, Natasha M., Nayak-Kapoor, Asha, Liu, Kebin
Published 2022Text -
8
Autocrine IL6-mediated activation of the STAT3-DNMT axis silences the TNFα-RIP1 necroptosis pathway to sustain survival and accumulation of myeloid-derived suppressor cells by Smith, Alyssa D., Lu, Chunwan, Payne, Daniela, Paschall, Amy V., Klement, John D., Redd, Priscilla S., Ibrahim, Mohammed L., Yang, Dafeng, Han, Qimei, Liu, Zhuoqi, Shi, Huidong, Hartney, Thomas J., Nayak-Kapoor, Asha, Liu, Kebin
Published 2020Text -
9
Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors by Nayak-Kapoor, Asha, Hao, Zhonglin, Sadek, Ramses, Dobbins, Robin, Marshall, Lisa, Vahanian, Nicholas N., Jay Ramsey, W., Kennedy, Eugene, Mautino, Mario R., Link, Charles J., Lin, Ray S., Royer-Joo, Stephanie, Liang, Xiaorong, Salphati, Laurent, Morrissey, Kari M., Mahrus, Sami, McCall, Bruce, Pirzkall, Andrea, Munn, David H., Janik, John E., Khleif, Samir N.
Published 2018Text